ArticlePloS one2017

Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma.

Seulki Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.